Todos Med Ltd (TOMDF)

[redspeed]

I've been following these trials in Japan of a 3CL Protease Inhibitor like Tollovid/r, but a drug. Actually a drug with adverse side effects.

Small trial. Just completed their Phase 2a.

I know, I know what's taking them so long.

"Treatment-emergent adverse events (TEAEs) were reported in 11 (52.4%), 16 (69.6%), and 9 (37.5%) patients in the ensitrelvir 125?mg, ensitrelvir 250?mg, and placebo groups, respectively, all of which were mild to moderate in severity. "

Their stock a little down on the news and down 50% YTD..

Seems to be only 1 car is the race rounding turn 4 and the rest stuck in pit row with flat tires.

A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part

13 September 2022

https://journals.asm.org/doi/10.1128/aac.00697-22


Safety, Tolerability, and Pharmacokinetics of the Novel Antiviral Agent Ensitrelvir Fumaric Acid, a SARS-CoV-2 3CL Protease Inhibitor, in Healthy Adults

12 September 2022

https://journals.asm.org/doi/full/10.1128/aac.00632-22?af=R